Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Jamie E Flerlage"'
Autor:
Adrian Damek, Lars Kurch, Friedrich Christian Franke, Andishe Attarbaschi, Auke Beishuizen, Michaela Cepelova, Francesco Ceppi, Stephen Daw, Karin Dieckmann, Ana Fernández-Teijeiro, Tobias Feuchtinger, Jamie E. Flerlage, Alexander Fosså, Thomas W. Georgi, Dirk Hasenclever, Andrea Hraskova, Jonas Karlen, Tomasz Klekawka, Regine Kluge, Dieter Körholz, Judith Landman-Parker, Thierry Leblanc, Christine Mauz-Körholz, Markus Metzler, Jane Pears, Jonas Steglich, Anne Uyttebroeck, Dirk Vordermark, William Hamish Wallace, Walter Alexander Wohlgemuth, Dietrich Stoevesandt
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Hypodense volumes (HDV) in mediastinal masses can be visualized in a computed tomography scan in Hodgkin lymphoma. We analyzed staging CT scans of 1178 patients with mediastinal involvement from the EuroNet-PHL-C1 trial and explored correlat
Externí odkaz:
https://doaj.org/article/56fe25c1577a4d6ebc0c24ea6b216610
Autor:
Jennifer Seelisch, Sue C. Kaste, Kara M. Kelly, Lars Kurch, Michael P. Link, Christine Mauz-Koerholz, Kathleen Mccarten, Angela Punnett, Dietrich Stroevesandt, Jamie E. Flerlage
Publikováno v:
HemaSphere, Vol 6, Pp 41-42 (2022)
Externí odkaz:
https://doaj.org/article/956c2c0f73c0491b9c4c6106cf0bb179
Autor:
Jamie E. Flerlage, Suzi Birz, Sharon M. Castellino, Burton Appel, Brian Furner, Luca Graglia, Tara O. Henderson, David Hodgson, Bradford S. Hoppe, Justine Kahn, Frank G. Keller, Sandy Kessel, Chen Li, Mei Li, John Lucas, Kathleen Mccarten, Monika Metzger, Sarah Milgrom, Susan K. Parsons, Qinglin Pei, Yue Wu, Yiwang Zhou, Michael Watkins, Sam Volchenbaum, Kara M. Kelly
Publikováno v:
HemaSphere, Vol 6, Pp 39-40 (2022)
Externí odkaz:
https://doaj.org/article/e0e48182938a4dbc857e1dbff0bc42e0
Autor:
Katelyn N. Purvis, Hope D. Swanson, Kumar Kulldeep Niloy, Yiwang Zhou, John C. Panetta, Kristine R. Crews, Jamie E. Flerlage
Publikováno v:
Cancer Chemotherapy and Pharmacology.
Autor:
Christopher Jon Forlenza, Jaclyn Rosenzweig, Audrey Mauguen, Ilia N. Buhtoiarov, Branko Cuglievan, Hema Dave, Rebecca Deyell, Jamie E Flerlage, Anna R. K. Franklin, Jennifer Krajewski, Kasey J. Leger, Lianna J. Marks, Robin E Norris, Martha Pacheco, Faye K Willen, Adam Paul Yan, Paul Harker-Murray, Lisa Giulino-Roth
Publikováno v:
Blood Advances.
Outcomes for children and adolescents with relapsed and refractory Hodgkin lymphoma (HL) are poor, with approximately 50% of patients experiencing a subsequent relapse. The anti-CD30 antibody-drug conjugate brentuximab vedotin improved progression-fr
Autor:
Viswatej Avutu, Varun Monga, Nupur Mittal, Aniket Saha, Jeffrey R. Andolina, Danielle E. Bell, Douglas B. Fair, Jamie E. Flerlage, Jamie N. Frediani, Jessica L. Heath, Justine M. Kahn, Jennifer L. Reichek, Leanne Super, Michael A. Terao, David R. Freyer, Michael E. Roth
Publikováno v:
JCO Oncol Pract
Adolescents and young adults (AYAs; age 15-39 years) with cancer are under-represented in cancer clinical trials because of patient, provider, and institutional barriers. Health care technology is increasingly available to and highly used among AYAs
Autor:
Frances B. Maguire, Qian Li, Elysia Alvarez, Justine M. Kahn, Renata Abrahão, Jamie E. Flerlage, Theresa H.M. Keegan
Publikováno v:
Cancer
Cancer, vol 127, iss 24
Cancer, vol 127, iss 24
BackgroundHodgkin lymphoma (HL) is a treatable tumor affecting children, adolescents and young adults (AYAs; 15-39 years old). Population-based studies report worse survival for non-White children and AYAs but have limited data on individual therapeu
Autor:
Stephanie A. Terezakis, Louis S. Constine, Jamie E. Flerlage, Bradford S. Hoppe, Karin Dieckmann, Eve Gallop-Evans, David R. W. Hodgson, John T. Lucas, Monika L. Metzger, Matthew Hall
Publikováno v:
International journal of radiation oncology, biology, physics
Radiotherapy (RT) technology and utilization has considerably evolved over the last 50 years in the management of pediatric Hodgkin lymphoma (HL). In response to significant late effects from RT in HL survivors, clinical trials in the United States a
Autor:
Belinda N. Mandrell, Alison M. Friedmann, Barry L. Shulkin, Monika L. Metzger, Matthew J. Krasin, Sandra Luna-Fineman, John T. Lucas, Sue C. Kaste, Susan M. Hiniker, Jamie E. Flerlage, Chen Li, Amy L. Billett, Nickhill Bhakta, Matthew J. Ehrhardt, Eric Larsen, Michael P. Link, Melissa M. Hudson, Torunn I. Yock, Pedro A. de Alarcon, Zhaohua Lu, Sarah S. Donaldson
Publikováno v:
J Clin Oncol
PURPOSE Brentuximab vedotin, an effective anti-CD30 antibody-drug conjugate approved for use in adults with classical Hodgkin lymphoma (HL), was introduced in this frontline trial to reduce prescribed radiation in children and adolescents with classi
Autor:
Andrea Garofalo, Stefan K. Alig, Joseph Schroers-Martin, Ragini Malika Shyam, Mari Olsen, David M. Kurtz, Cédric Rossi, Andre Schultz, Karan R. Kathuria, Chih Long Liu, Valeria Spina, Jamie E. Flerlage, Sharon M. Castellino, Ranjana H. Advani, Davide Rossi, Ryan C. Lynch, Olivier Casasnovas, Lianna J. Marks, Michael P. Link, Marc Andre, Peter Vandenberghe, Christian Steidl, Maximilian Diehn, Ash A. Alizadeh
Publikováno v:
Blood. 140:1318-1319